Using IHC when HER2 expression was observed, there was a difference in expression of HER2 in ovarian clear cell carcinoma and endometrial clear cell carcinoma and there was a marked discordance in ISH [22]. This evidence concerns the gene ERBB2 and ovarian clear cell cancer.